According to GlobalData’s medical device pipeline database, 37 Mammography Equipment devices are in various stages of development globally. GlobalData’s report Mammography Equipment provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, 18 are in active development, while the remaining 20 are in an inactive stage of development. There are 12 products in the early stages of development, and the remaining six are in the late stages of development.

Mammography equipment is a type of medical imaging equipment that uses X-rays to capture images (mammograms) of the internal structures of the breasts. Mammography plays a key role in early diagnosis of breast cancer. 2D digital mammography equipment, breast tomosynthesis and retrofit breast tomosynthesis are covered in this category. Tracked here are the equipment only and not accessories and/or additional costs associated with mammography equipment installation. One unit refers to One mammography equipment.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Mammography Equipment pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Mammography Equipment devices. Overall, most of these Mammography Equipment pipeline devices are being developed by private entities.

Key players involved in the active development of Mammography Equipment include Fischer Imaging, CapeRay Medical, Imaging Diagnostic Systems, Philips Healthcare Informatics, Real Time Tomography, University of Manchester, TomoWave Laboratories, University at Buffalo, University College London and University of Canterbury.

For a complete picture of the developmental pipeline for Mammography Equipment devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.